Home Page: Clinical Genitourinary Cancer

Skip to Main Content

Articles in Press

Original Study
Combining CAPRA-S with tumor IDC/C features improves the prognostication of biochemical recurrence in prostate cancer patients
Published online: January 14, 2022
Original Study
Hereditary Cancer Gene Variants in Hispanic Men with a Personal or Family History of Prostate Cancer
Published online: January 14, 2022
Original Study
Impact of ¹⁸ FDG- PET CT in the management of Muscle Invasive Bladder Cancer
Published online: January 14, 2022
Original Study
Open Access
Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups
Published online: January 12, 2022

About

Cover Image - Clinical Genitourinary Cancer, Volume 19, Issue 6

Cover Image - Clinical Breast Cancer, Volume 22, Issue 1

Cover Image - Clinical Colorectal Cancer, Volume 20, Issue 4

Cover Image - Clinical Lung Cancer, Volume 23, Issue 1

Cover Image - Clinical Lymphoma, Myeloma and Leukemia, Volume 22, Issue 1

Metrics

Most Read (Last 30 Days)

Original Study
Open Access
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States
Published online: January 7, 2020
Review
Open Access
Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer
Published online: September 26, 2019
Original Study
Open Access
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
Published online: October 12, 2021
Original study
Open Access
Time to Resolution of Axitinib-Related Adverse Events After Treatment Interruption in Patients With Advanced Renal Cell Carcinoma
Published online: April 4, 2021
Case Series
Open Access
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series
Published online: December 16, 2021
Original Study
Open Access
Management of Patients With Advanced Urothelial Carcinoma in an Evolving Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line Therapies
Published online: November 12, 2021

Most Cited (Previous 3 Years)

Results of a Prospective Phase 2 Pilot Trial of ¹⁷⁷ Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression
Emmett et al.
Clinical Genitourinary Cancer, Vol.17, No.1, p15-22
February 2019
Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study
Saad et al.
Clinical Genitourinary Cancer, Vol.17, No.1, p46-57.e5
February 2019
Open Access
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States
George et al.
Clinical Genitourinary Cancer, Vol.18, No.4, p284-294
August 2020
Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer
Gao et al.
Clinical Genitourinary Cancer, Vol.17, No.3, p183-190
June 2019
Open Access
Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer
Zhang et al.
Clinical Genitourinary Cancer, Vol.18, No.1, p1-10
February 2020
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
Paller et al.
Clinical Genitourinary Cancer, Vol.17, No.4, p275-282.e1
August 2019